Ken Song is the founder of Omniome. Omniome has raised $120M in total funding. Latest round: Series C. Based in San Diego, Country (or null).
Ken Song, M.D., served as the Executive Chairman at Omniome, a company dedicated to developing a novel DNA sequencing platform. Under his leadership, Omniome focused on creating a disruptive sequencing technology with high accuracy, speed, throughput, and cost-effectiveness.
Full founder directory · Investor directory · Company funding database · Fundraising library